HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vaccination with syngeneic, lymphoma-derived immunoglobulin idiotype combined with granulocyte/macrophage colony-stimulating factor primes mice for a protective T-cell response.

Abstract
The idiotype of the Ig expressed by a B-cell malignancy (Id) can serve as a unique tumor-specific antigen and as a model for cancer vaccine development. In murine models of Id vaccination, formulation of syngeneic Id with carrier proteins or adjuvants induces an anti-idiotypic antibody response. However, inducing a potent cell-mediated response to this weak antigen instead would be highly desirable. In the 38C13 lymphoma model, we observed that low doses of free granulocyte/macrophage colony-stimulating factor (GM-CSF) 10,000 units i.p. or locally s.c. daily for 4 days significantly enhanced protective antitumor immunity induced by s.c. Id-keyhole limpet hemocyanin (KLH) immunization. This effect was critically dependent upon effector CD4+ and CD8+ T cells and was not associated with any increased anti-idiotypic antibody production. Lymphocytes from spleens and draining lymph nodes of mice primed with Id-KLH plus GM-CSF, but not with Id-KLH alone, demonstrated significant proliferation to Id in vitro without any biased production of interferon gamma or interleukin 4 protein or mRNA. As a further demonstration of potency, 50% of mice immunized with Id-KLH plus GM-CSF on the same day as challenge with a large s.c. tumor inoculum remained tumor-free at day 80, compared with 17% for Id-KLH alone, when immunization was combined with cyclophosphamide. Taken together, these results demonstrate that GM-CSF can significantly enhance the immunogenicity of a defined self-antigen and that this effect is mediated exclusively by activating the T-cell arm of the immune response.
AuthorsL W Kwak, H A Young, R W Pennington, S D Weeks
JournalProceedings of the National Academy of Sciences of the United States of America (Proc Natl Acad Sci U S A) Vol. 93 Issue 20 Pg. 10972-7 (Oct 01 1996) ISSN: 0027-8424 [Print] United States
PMID8855293 (Publication Type: Journal Article)
Chemical References
  • Adjuvants, Immunologic
  • Antibodies, Anti-Idiotypic
  • Cancer Vaccines
  • Immunoglobulin Idiotypes
  • Recombinant Proteins
  • Granulocyte-Macrophage Colony-Stimulating Factor
Topics
  • Adjuvants, Immunologic
  • Animals
  • Antibodies, Anti-Idiotypic (biosynthesis)
  • Antibody Formation (drug effects)
  • Cancer Vaccines (immunology)
  • Female
  • Granulocyte-Macrophage Colony-Stimulating Factor (pharmacology)
  • Immunity, Cellular (drug effects)
  • Immunoglobulin Idiotypes (immunology)
  • Immunotherapy
  • Lymphoma, B-Cell (immunology, therapy)
  • Mice
  • Mice, Inbred C3H
  • Recombinant Proteins
  • T-Lymphocytes (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: